Literature DB >> 3335645

Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures.

J D Cashman1, C J Eaves, A C Eaves.   

Abstract

Marrow cells from seven untreated patients with polycythemia vera (PV) were used to initiate standard single inoculum long-term marrow cultures. The numbers, erythropoietin independence, and cycling behavior of all detectable classes of erythroid, granulopoietic, and multilineage progenitors were then evaluated and the results obtained compared with preculture values. Time course studies showed that the long-term marrow culture system supports the continuous proliferation of primitive neoplastic progenitor cells from PV patients for many weeks. However, these progenitors fail to respond to signals from the adherent layer that return their counterparts in normal long-term marrow cultures to a quiescent state 5-7 d after each medium change. This abnormal cycling behavior of PV cells in the long-term culture system appears to mimic that operative in vivo, where primitive hemopoietic progenitors are also in a continuous state of turnover, in contrast to similar primitive progenitor compartments in normal individuals, which are quiescent. The long-term marrow culture system thus offers new possibilities for the further analysis of abnormal cellular and molecular mechanisms underlying clonal expansion at the stem cell level in PV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335645      PMCID: PMC442477          DOI: 10.1172/JCI113315

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

Review 1.  Erythropoiesis in culture.

Authors:  A C Eaves; C J Eaves
Journal:  Clin Haematol       Date:  1984-06

2.  Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

Authors:  L Coulombel; A C Eaves; C J Eaves
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

3.  Pluripotent hemopoietic progenitors (CFU-GEMM) in polycythemia vera: analysis of erythropoietin requirement and proliferative activity.

Authors:  A A Fauser; H A Messner
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

4.  Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow.

Authors:  J S Powell; P J Fialkow; J W Adamson
Journal:  J Cell Physiol Suppl       Date:  1982

5.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

6.  Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.

Authors:  J F Prchal; J W Adamson; S Murphy; L Steinmann; P J Fialkow
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

7.  Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia.

Authors:  J Lepine; H A Messner
Journal:  Int J Cell Cloning       Date:  1983-09

8.  Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.

Authors:  J Eid; R F Ebert; M S Gesell; J L Spivak
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Characteristics of circulating erythroid colony-forming cells in normal and polycythaemic man.

Authors:  J Mladenovic; J W Adamson
Journal:  Br J Haematol       Date:  1982-07       Impact factor: 6.998

10.  Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine.

Authors:  J W Singer; P J Fialkow; J W Adamson; L Steinmann; C Ernst; S Murphy; K J Kopecky
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

View more
  3 in total

1.  Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.

Authors:  G Bazzoni; N Carlesso; J D Griffin; M E Hemler
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.

Authors:  Catriona H M Jamieson; Jason Gotlib; Jeffrey A Durocher; Mark P Chao; M Rajan Mariappan; Marla Lay; Carol Jones; James L Zehnder; Stan L Lilleberg; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

3.  Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.

Authors:  C H Dai; S B Krantz; R T Means; S T Horn; H S Gilbert
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.